Plerixafor vs placebo
Adverse events (during stem cell mobilisation and collection) · People with haematopoietic stem cell mobilisation for autologous transplantation in malignant lymphoma or multiple myeloma
Plerixafor showed no clear difference in adverse events (during stem cell mobilisation and collection) compared with placebo (high certainty).
1 finding from 1 review
- Additional plerixafor to granulocyte colony‐stimulating factors for haematopoietic stem cell mobilisation for… 2015 · Cochrane Headline outcomes onlyRR 1.02 [0.99, 1.06]2 studies · 593 participantsHigh